QIAGEN Stock Likely to Gain on Collaboration for APOE Genotyping [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
The QIAstat-Dx panel will be used to detect apolipoprotein E (APOE) genotypes. The QIAstat-Dx panel will be the first commercially available IVD for APOE genotyping. The recent collaboration is poised to enhance the company's Molecular Diagnostics business. Shares of QGEN were up 0.4% in pre-market trading today following the news. With the company gaining a high level of synergies due to its continued spree of companion diagnostics collaborations, we expect market sentiment to remain positive around this development. More on QIAGEN's Collaboration With Lilly The new QIAstat-Dx IVD panel, being developed through the collaboration with Eli Lilly, will enable QIAGEN to enhance treatment for Alzheimer's patients by providing valuable insight into their diagnostic journey. The QIAstat-Dx IVD panel will detect all APOE genotypes (APOE2, APOE3, APOE4). People carrying the APOE4 genotype have a higher risk of developing Alzheimer's and are likely to do so earlier in life compared wit
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platformGlobeNewswire
- QGEN Stock Likely to Gain From Innovation Amid Competition [Yahoo! Finance]Yahoo! Finance
- Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance? [Yahoo! Finance]Yahoo! Finance
- QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil’s national screening programsGlobeNewswire
- With 79% institutional ownership, Qiagen N.V. (NYSE:QGEN) is a favorite amongst the big guns [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 7/31/24 - Beat
QGEN
Sec Filings
- 9/11/24 - Form 144
- 9/4/24 - Form 6-K
- 9/3/24 - Form 6-K
- QGEN's page on the SEC website